Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study of ET743 in Subjects With Advanced Liposarcoma or Leiomyosarcoma
This study is ongoing, but not recruiting participants.
Study NCT00060944   Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
First Received: May 16, 2003   Last Updated: December 27, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Liposarcoma
Leiomyosarcoma
More general conditions related to this trial
Neoplasms
Neoplasms by Histologic Type
Neoplasms, Adipose Tissue
Neoplasms, Connective and Soft Tissue
Neoplasms, Muscle Tissue
Sarcoma
Interventions listed in this trial
Yondelis
Additional drug interventions recognized in this trial
Ecteinascidin 743
More general drug interventions related to this trial
Alkylating Agents
Antineoplastic Agents
Antineoplastic Agents, Alkylating
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Johnson &Johnson Pharmaceutical Research &Development, L.L.C.
PharmaMar


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services